Yoga added to standard buprenorphine treatment helped people in early opioid withdrawal feel better, sleep better, and stabilize faster than buprenorphine alone, according to a randomized clinical trial just published in JAMA Psychiatry. Participants who attended ten 45-minute yoga sessions over two weeks reached withdrawal stabilization 4.4 times faster than the control group — with the median time to stabilization cut from 9 days to 5.
What Happened
Researchers at an addiction medicine inpatient ward in India enrolled 59 adults with opioid use disorder who were in mild-to-moderate withdrawal — Clinical Opiate Withdrawal Scale (COWS) scores between 4 and 24. Every participant received buprenorphine, the gold-standard medication for opioid withdrawal. Half were randomly assigned to additionally receive a structured yoga program: ten supervised 45-minute sessions delivered over a two-week period.
The trial’s primary endpoint was time to withdrawal stabilization. By that measure, the yoga arm reached stabilization at a median of 5 days, compared with 9 days in the buprenorphine-only arm — a 4.4-fold acceleration in the per-day probability of stabilization. Secondary endpoints fared similarly: yoga participants showed greater improvements in heart rate variability — a marker of autonomic nervous system regulation that withdrawal famously disrupts — and in anxiety, sleep, and pain.
The paper, titled “Yoga for Opioid Withdrawal and Autonomic Regulation: A Randomized Clinical Trial,” was published in JAMA Psychiatry in 2026.
Why It Matters
Opioid withdrawal is one of the most physiologically violent processes the human body goes through. Surges of sympathetic nervous system activity drive racing heart rate, blood pressure spikes, sweating, restless legs, and a kind of anxiety that most patients describe as the hardest part of the entire experience. Buprenorphine helps, but it doesn’t switch off the autonomic storm — it only takes the top off it.
What makes this trial interesting is the mechanism the authors propose. By targeting heart rate variability and parasympathetic tone directly, yoga appears to do something pharmacology cannot: it teaches the autonomic nervous system to settle. That distinction matters in clinical context, because dropout during the first 14 days is closely tied to how brutal the withdrawal experience feels at day three or four. A faster, gentler stabilization curve doesn’t just feel better — it keeps more people in treatment.
It also matters because this is a JAMA Psychiatry trial, not a small wellness-journal pilot. JAMA Psychiatry is one of the highest-impact journals in clinical psychiatry, and publication there carries weight with the addiction-medicine establishment that yoga research has historically struggled to reach.
Inside The Trial Design
The study screened 68 inpatients and randomized 59 — 30 to yoga + buprenorphine, 29 to buprenorphine alone — between April 2023 and March 2024. Eligibility was adults aged 18 to 50 with confirmed opioid use disorder and a COWS score between 4 and 24 at admission, capturing patients who were uncomfortable but not in life-threatening severe withdrawal.
Participants in the yoga arm attended ten 45-minute sessions, delivered roughly every other day over the two-week window. Each session was supervised by a trained yoga therapist. The buprenorphine protocol followed standard inpatient practice for both arms, and assessments included repeated COWS scoring, heart rate variability monitoring, anxiety inventories, sleep diaries, and pain ratings.
Because the population was a single inpatient cohort in India and skewed toward men, the authors are cautious about generalizing the size of the effect. But the direction of the result — yoga as a meaningful adjunct in early withdrawal — replicates a growing pattern across the literature on autonomic-regulation interventions.
Which Yoga Practices Were Used
The intervention drew from classical hatha yoga adapted for clinical use. Each session combined gentle asana, pranayama (breath regulation), and guided relaxation. Notable elements included slow seated forward folds, supine chest openers, supported reclined poses, alternate nostril breathing (nadi shodhana), and an extended savasana with a body scan.
Alternate nostril breathing is worth flagging because it appears repeatedly in autonomic-regulation studies and was likely a major driver of the heart rate variability improvements observed here. For a primer on the practice, see our guide to nadi shodhana, which lays out the technique and the underlying nervous-system rationale. The supine and supported elements of the protocol overlap heavily with restorative yoga — a style specifically designed to downshift the sympathetic nervous system — covered in our restorative yoga guide.
What This Means For You
If you or someone you support is going through opioid withdrawal — or any acute autonomic crisis, including post-surgical recovery, severe insomnia, or generalized anxiety — three practical takeaways from this trial transfer well outside the inpatient setting.
First, frequency matters more than intensity. The protocol used in the trial was not vigorous yoga; it was gentle, repeated, and supervised. Ten 45-minute sessions in two weeks is roughly five sessions a week. That density of practice — short and near-daily — appears to be what shifts the autonomic baseline.Second, breathwork was central, not a footnote. Alternate nostril breathing, slow-exhale techniques, and extended exhalations were the practices most directly tied to the heart rate variability gains. If you can only carve out 10 minutes, make them breathwork minutes. Our yoga for anxiety guide walks through the specific patterns shown to calm the nervous system on the fastest timescale.
Third, sleep onset improved alongside withdrawal scores. Opioid withdrawal famously wrecks sleep, but so do many other states — perimenopause, chronic pain, post-COVID recovery. The supine-yoga + extended-savasana element of this protocol mirrors what we recommend in our yoga for insomnia guide, and the mechanism is the same: park the sympathetic nervous system long enough for the parasympathetic system to lead.
Worth noting clearly: yoga is an adjunct in this study, not a substitute. Every participant received buprenorphine. Anyone undergoing opioid withdrawal should be in medical care; the takeaway from JAMA Psychiatry is that yoga added on top of that medical care delivers measurable, meaningful gains — not that yoga alone is a withdrawal protocol.
Key Takeaways
A JAMA Psychiatry RCT of 59 inpatients with opioid use disorder found that adding ten 45-minute yoga sessions over two weeks to standard buprenorphine treatment cut the median time to withdrawal stabilization from 9 to 5 days — a 4.4-fold acceleration in the per-day probability of stabilizing. The yoga arm also showed improvements in heart rate variability, anxiety, sleep, and pain. The protocol combined gentle hatha postures with pranayama (especially nadi shodhana) and supported relaxation.
The setting is part of a wider Indian push toward standardised yoga protocols for chronic disease, which we covered in our report on the AYUSH national yoga protocols. For everyone outside the inpatient context — recovering from surgery, navigating chronic pain, or simply trying to repair sleep — the lessons travel: short, frequent, breath-anchored sessions outperform long, occasional ones for autonomic recovery.
